Department of Health and Human Services, through National Institutes of Health, awarded Monod Bio, Inc. of Seattle, WA $377,260 under the SBIR program (Phase I), with work starting 2026-08-01 and running to 2027-05-31. It is one of 2 SBIR and STTR awards Monod Bio, Inc. received in the last two years, $708,215 in all. Each figure links to the federal record.
The award
| Recipient | Monod Bio, Inc. (Seattle, WA) |
|---|---|
| Awarding agency | Department of Health and Human Services |
| Awarding office | National Institutes of Health |
| Phase | Phase I |
| Amount obligated | $377,260 |
| Period of performance starts | 2026-08-01 |
| Period of performance ends | 2027-05-31 |
| Award number | R44GM161195 (grant, CFDA 93.859) |
| Assistance listing | 93.859, Biomedical Research and Research Training |
| Place of performance | Seattle, King County, WA |
| Signed | 2026-08-03 |
| Recipient registry id (UEI) | LB2HDKKRL463 |
Want the whole picture on Monod Bio, Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Monod Bio, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Monod Bio, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
2 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
What it is for
Design of rapid and quantitative biosensors with computational protein design - project summary monod bio’s fast-track proposal aims to advance the novolisa™ technology, transforming biosensing methods in life sciences r
Funding actions on this award
| Date | Action | Modification | Amount |
|---|---|---|---|
| 2026-08-03 | New | 000 | $377,260 |
Design of rapid and quantitative biosensors with computational protein design - project summary monod bio’s fast-track proposal aims to advance the novolisa™ technology, transforming biosensing methods in life sciences research. Traditional biosensing approaches, such as elisas, face significant limitations, including prolonged time-to-results (90–270 minutes), complex procedures, extensive antibody development times, and the risk of cross-reactivity due to insufficient antibody validation. In contrast, monod bio’s novolisa assay offers a rapid (<15 minutes), single-step, no-wash solution that utilizes computationally designed proteins (novobodies) as reagents. Novobodies serve as effective alternatives to traditional antibodies, developed in just 4-5 weeks, and are used in assays powered by monod bio’s proprietary split luciferase system, luxsit pro™. This system enables quick, accurate biomarker detection via luminescence using standard plate readers, which are widely available in research labs. Monod bio has already developed a sensitive novolisa assay for c-reactive protein (crp) and is working on additional assays for key biomarkers, including IL-6, tnf-α, and psa. Phase I of this project focuses on enhancing the sensitivity and adaptability of these assays for a broader range of laboratory environments, with specific goals to improve performance metrics such as limit of d ...
From the federal award record.
Other SBIR and STTR awards to Monod Bio, Inc.
| Starts | Agency | Program | Amount | Project |
|---|---|---|---|---|
| 2026-08-01 | Department of Health and Human Services | SBIR Phase I | $330,955 | Computational protein design of robust and scalable recombinant hrp and poly-hrp reagents (record) |
Who runs it, who owns it, where the money comes from and what to watch for, every claim linked to its source.
Order Full Report on Monod Bio, Inc.Look up Monod Bio, Inc. and see what is on record before you decide.
Get the free SnapshotWhere this comes from
The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs set aside part of federal research budgets for small companies. Agencies award them in phases: Phase I tests whether an idea is feasible, Phase II funds development, and Phase III is follow-on work paid for outside the set-aside. STTR awards also require a research institution as a partner.
Every figure on this page is taken from the award's own federal record, linked beside it, as it stood when the page was built: the recipient, its address, the awarding agency and office, the amount obligated so far, the dates and the description. Phase and program are shown as the award's own description states them. The amount can grow later if the agency adds funding to the same award.